Dr. Orbuch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
179 Sullivan St
New York, NY 10012Phone+1 212-688-0813Fax+1 877-991-2905
Education & Training
- MedStar Health/Georgetown University HospitalFellowship, Gastroenterology, 1991 - 1994
- NYU Grossman School of MedicineResidency, Internal Medicine, 1987 - 1990
- State University of New York Downstate Medical Center College of MedicineClass of 1987
Certifications & Licensure
- AZ State Medical License 2009 - 2026
- CA State Medical License 2020 - 2026
- FL State Medical License 1995 - 2026
- NY State Medical License 1989 - 2026
- VI State Medical License 2021 - 2024
- MD State Medical License 1991 - 1995
- American Board of Internal Medicine Gastroenterology
- National Board of Physicians and Surgeons Gastroenterology
- National Board of Physicians and Surgeons Internal Medicine
Awards, Honors, & Recognition
- Top Doctors of New York Castle Connolly, 2015-2023
- Super Doctor SuperDoctors.com, 2011-2023
Clinical Trials
- Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis Start of enrollment: 2018 Aug 07
- Open-label Extension Study of Brazikumab in Crohn's Disease Start of enrollment: 2020 Jan 06
Publications & Presentations
PubMed
- 45 citationsProlonged hypergastrinemia does not increase the frequency of colonic neoplasia in patients with Zollinger-Ellison syndromeMurray Orbuch, David Venzon, Irina A. Lubensky, Horst C. Weber, Fathia Gibril
Digestive Diseases and Sciences. 1996-03-01 - 69 citationsUse of omeprazole in Zollinger-Ellison syndrome: a prospective nine-year study of efficacy and safetyDavid C. Metz, Doris B. Strader, Murray Orbuch, Pamela D. Koviack, Kathryn Feigenbaum
Alimentary Pharmacology & Therapeutics. 2007-03-31 - 337 citationsDeterminants of Metastatic Rate and Survival in Patients With Zollinger-Ellison Syndrome: A Prospective Long-term StudyH. Christian Weber, David Venzon, Jaw-Town Lin, Vitaly A. Fishbein, Murray Orbuch
Gastroenterology. 1995-06-01
Other Languages
- Hebrew
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: